NCT07126028

Brief Summary

The aim of this observational study is to assess whether Multisystem Inflammatory Syndrome (MIS-C) in children affects their quality of life. The investigators will examine whether there is a correlation between paediatric mortality prediction scoring systems, specific clinical and laboratory indicators, and whether some of these can predict the level of quality of life in children 24 months after hospital discharge. The primary questions are: Do children who survived MIS-C have a poorer quality of life 24 months after the illness compared to their peers? Can investigators identify prognostic indicators to create preventative strategies for MIS-C? The investigator will compare the quality of life in participants who survived MIS-C with a control group. The quality of life will be measured using a validated questionnaire. In the first phase, data from medical records will be collected. In the second, prospective part of the study, participants, healthy peers, and their parents or guardians will be asked to complete a questionnaire about quality of life.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
85

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

August 2, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 15, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

August 17, 2025

Status Verified

August 1, 2025

Enrollment Period

1.3 years

First QC Date

August 2, 2025

Last Update Submit

August 15, 2025

Conditions

Keywords

risk adjustmentquality of lifeMultisystem inflammatory Syndrome in Children

Outcome Measures

Primary Outcomes (2)

  • To assess the quality of life of children with and treated for MIS-C 24 months after hospital discharge

    The quality of life of all surviving children with MIS-C will be examined using a validated questionnaire for at least 24 months from discharge from the hospital. The quality of life will be assessed using a questionnaire completed based on age, by parents or guardians for children under five, and by children over five years old themselves. The questionnaire used is the "Pediatric Quality of Life Inventory™ Generic Core Scales (PedsQL™ Generic Core Scales)." It investigates and gathers responses related to physical health and activity, emotional health, social activities, and school or kindergarten activities. Each response can score between 0 and 4 points, where 0 indicates the best outcome and 4 the worst. The responses are reverse-scored and linearly transformed into a scale so that higher scores represent better quality of life (for 0 = 100, 1 = 75, 2 = 50, 3 = 25, and 4 = 0).

    from enrollment (24 weeks after hospital discharge) to the end of completing the questionnaire at 12 weeks

  • The quality of life of healthy peers

    A control group of peers (healthy participants) of the same age and sex will complete the questionnaire. The quality of life will be assessed using a questionnaire completed based on age, by parents or guardians for children under five, and by children over five years old themselves. The questionnaire used is the "Pediatric Quality of Life Inventory™ Generic Core Scales (PedsQL™ Generic Core Scales)." It investigates and gathers responses related to physical health and activity, emotional health, social activities, and school or kindergarten activities. Each response can score between 0 and 4 points, where 0 indicates the best outcome and 4 the worst. The responses are reverse-scored and linearly transformed into a scale so that higher scores represent better quality of life (for 0 = 100, 1 = 75, 2 = 50, 3 = 25, and 4 = 0).

    From enrollment to the end of completing the questionnaire at 12 weeks.

Study Arms (2)

MIS-C group

those children who survived MIS-C and were treated in the hospital

control Group

healthy peers without any acute diseases or chronic conditions

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The subjects will be recruited by the primary care physician, who is also the responsible physician for the control patient treated by MIS-C, through random selection from the hospital records of children of the desired age. The responsible physician will then contact the parent of the potential healthy subject and offer them the opportunity to participate in the study.

You may qualify if:

  • children of the same age and gender as the children in MIS-C group

You may not qualify if:

  • history of acute hospitalisations in hospitals for any reason
  • chronic health problems (including chronic childhood diseases and chronic physical disabilities)
  • Examples of chronic diseases include:
  • childhood asthma
  • cystic fibrosis
  • congenital heart defects
  • diabetes mellitus
  • epilepsy
  • chronic inflammatory bowel disease
  • celiac disease
  • rheumatological diseases such as juvenile idiopathic arthritis
  • psychiatric disorders (e.g., attention deficit hyperactivity disorder and depression).
  • Examples of chronic physical disabilities include:
  • hearing or vision impairment
  • cerebral palsy
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Hospital Centre Rijeka, Department of Paediatrics

Rijeka, Primorje-Gorski Kotar County, 51000, Croatia

Location

MeSH Terms

Conditions

pediatric multisystem inflammatory disease, COVID-19 related

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
12 Weeks
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
assoc. prof.

Study Record Dates

First Submitted

August 2, 2025

First Posted

August 15, 2025

Study Start

April 1, 2024

Primary Completion

July 31, 2025

Study Completion

December 31, 2025

Last Updated

August 17, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

All information about the investigation plan: recruitment methods, statistics used in the study and results after completing the research.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
May 2026 - December 2026

Locations